在lncRNAs和癌症性别二态之间出现的联系
Ikrame Naciri1, Maria D Andrade-Ludena1, Ying Yang2
1Department of Developmental and Cell Biology, School of Biological Sciences, University of California Irvine, Irvine, CA, 92697, USA.
Human genetics
|December 14, 2023
概括
长非编码RNAs (lncRNAs) 影响癌症发育和进展的性别差异. 了解 lncRNAs 的理解
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 癌症发病率,进展和治疗反应在男性和女性之间表现出显著的差异,这一现象被称为癌症性别变态.
- 长非编码RNAs (lncRNAs) 是基因表达和细胞过程的关键调节者,越来越多地涉及到各种疾病,包括癌症.
- 新出现的证据表明,lncRNAs在调解癌症中观察到的基于性别的差异方面发挥着作用.
研究的目的:
- 为了概述当前对癌症性别二重变异中的lncRNAs的理解.
- 探索 lncRNAs 导致癌症性别差异的机制,重点关注表观遗传调节.
- 突出性别作为癌症研究和治疗开发中的生物变量的重要性.
主要方法:
- 文献综述和现有关于lncRNAs和癌症性别二重变异的研究的综合.
- 分析涉及 lncRNAs 在性别特异性癌症发展中的拟议机制.
- 讨论该领域未来研究的策略.
主要成果:
- lncRNAs参与了男性和女性细胞之间存在差异的表观遗传过程,这有助于癌症的性别变异.
- 潜在的机制包括lncRNA调节性染色体转录,荷尔蒙通路和免疫反应.
- lncRNAs代表了解决性别特异性癌症差异的潜在治疗点.
结论:
- lncRNAs正在成为癌症性别变异的关键参与者,影响表观遗传调节,并导致癌症的性别差异.
- 进一步研究癌症性质变异中的lncRNA功能对于推进个性化医学至关重要.
- 将性别视为一种生物变量,并针对 lncRNAs,有望改善男性和女性的癌症治疗结果.
更多相关视频
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
6.8K
11:12Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
8.0K
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
02:55The Nucleolus
8.9K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.9K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:46Epigenetic Regulation
31.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
03:18Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K